The United Kingdom is poised to provide NHS patients with access to new medicines previously deemed unaffordable under a sweeping agreement with the United States. Under the deal, NHS expenditure
Pharmaceutical5- Page
169Articles
Gilead’s TROP-2 drug Trodelvy misses its primary endpoint in a key phase 3 breast cancer trial, though early signs suggest possible survival benefits.
AstraZeneca has recorded its highest quarterly revenue to date, achieving a ten per cent increase and surpassing analyst expectations. The FTSE 100 pharmaceutical group announced total third quarter revenue had
The UK is facing mounting pressure from the United States to reform its drug pricing policies, with the US ambassador, Warren Stephens, delivering a stark ultimatum to government officials and
Kenvue, the American pharmaceutical firm behind the well-known paracetamol brand Tylenol, has been acquired for $49 billion (£37 billion) by consumer goods conglomerate Kimberly-Clark. The deal follows a tumultuous period
Two of the world’s largest pharmaceutical conglomerates have become embroiled in an escalating takeover battle for Metsera, an emerging biotech on the verge of breakthroughs in weight-loss drug innovation. Novo
The powerful Novo Nordisk Foundation, the largest shareholder in pharmaceutical giant Novo Nordisk, has executed a dramatic boardroom takeover after a sharp disagreement about the company’s strategic direction. The move,
AstraZeneca, the United Kingdom’s most valuable publicly listed company, has secured the backing of leading shareholder advisory groups for its proposal to achieve a direct listing on the New York
AstraZeneca has announced a major shift in its transatlantic pricing strategy, pledging to sharply reduce the cost of its medicines in the United States following mounting political pressure. The pharmaceutical
Senior figures within the British Medical Association (BMA) have ignited fierce debate following the leak of a letter suggesting that GPs should direct patients to A and E departments rather
Novo Nordisk, the Danish pharmaceutical giant best known for developing the weight-loss injection Wegovy, has announced a landmark deal to acquire US-listed biotech Akero Therapeutics for up to $5.2 billion.
Sir Keir Starmer is preparing to overhaul NHS value for money protocols in a high-stakes move that could see Britain pour billions more into pharmaceutical spending. This comes amid escalating
The Prime Minister recently convened with Sir Pascal Soriot, the chief executive of AstraZeneca, at Downing Street to discuss the government’s efforts to bolster UK capital markets. This meeting came
Billions of pounds were added to the market value of British and global pharmaceutical companies on Wednesday following a major relief rally prompted by the Trump administration’s latest stance on
Stefano Pessina, renowned for building the Walgreens Boots Alliance empire, has set the stage for Boots to become a standalone company after the sale of WBA to US private equity
Dame Emma Walmsley has announced her departure as chief executive of GSK, marking the end of a transformative chapter for one of Britain’s most prominent pharmaceutical firms. During her tenure